Frost & Sullivan Podcasts

Challenge Discussed : Microbiome technologies have been increasingly leading several industry transformations and 2019 will witness many new developments in this space. Frost & Sullivan believes that the growing research across microbiome science will deeply impact several industry sectors in the coming years.Speaker : Vandana IyerKey Takeaways :What is the direct impact on the pharmaceutical sector?1.   OTC probiotics - gut health –for while2.   Novel microbiome-based therapies for gastrointestinal disorders are likely to emerge this year3.   There’s a close competition between Seres Therapeutics and Rebiotix, as both advance their phase III orphan drug candidates for the prevention of clostridium difficile infection (CDI). Industry experts are sure to watch this space closely for any upcoming regulatory approvals.4.   Interestingly, genetic engineering platforms have caught up with skin microbiomics. Azitra is one of the niche players that is n